Two members of an FDA advisory committee have now resigned in protest over Monday's approval of Biogen's Alzheimer's disease drug Aduhelm despite an overwhelming vote against doing so. Washington ...
With the first patient set to receive Biogen's new Alzheimer's drug Aduhelm in Rhode Island today, US consumer advocacy organisation Public Citizen is deeply unhappy about the FDA's approval of ...
Marik was forced to resign his positions at Eastern Virginia Medical School and Sentara Norfolk General Hospital for promoting the use of ivermectin after the FDA’s actions, according to the ...
The method is usually used for cancer medications, according to CNBC. In his resignation letter, Kesselheim said the FDA switched its review to the accelerated pathway "at the last minute" based ...